Amerisource Health Services LLC recalls

29 recalls on record · latest: May 1, 2026

Official U.S. recall history for Amerisource Health Services LLC, compiled from official government records.

Get recall alerts

Free email alert whenever Amerisource Health Services LLC has a new recall — straight from official government data. Unsubscribe anytime.

Amerisource Health Services LLC recalls Primidone Tablets, USP, 250 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American H…

May 1, 2026 · Drug & medication recalls Cross contamination with other products: API contaminated with trace amounts of…

Amerisource Health Services LLC recalls Primidone Tablets, USP, 50 mg, 100 Tablets (10 x 10 unit dose blister) per carton, Rx only, Distributed by: American He…

May 1, 2026 · Drug & medication recalls Cross contamination with other products: API contaminated with trace amounts of…

Amerisource Health Services LLC recalls Oxycodone Hydrochloride Tablets, USP (CII), 5 mg, 100-Count (10 x 10) blister cards per carton, Rx Only, The drug produ…

January 14, 2026 · Drug & medication recalls Moderate risk Defective container: card seal defects (weak/non-existent seals), leading to th…

Amerisource Health Services LLC recalls Prazosin Hydrochloride, Capsules, USP, 1 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Pack…

October 16, 2025 · Drug & medication recalls Moderate risk Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin imp…

Amerisource Health Services LLC recalls Prazosin Hydrochloride, Capsules, USP, 2 mg, 100 capsules (10x10) cartons, Rx only, Distributed by American Health Pack…

October 16, 2025 · Drug & medication recalls Moderate risk Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin imp…

Amerisource Health Services LLC recalls Prazosin Hydrochloride, Capsules, USP, 5 mg, 20 capsules (5x4) cartons, Rx only, Distributed by American Health Packagi…

October 16, 2025 · Drug & medication recalls Moderate risk Failed Impurities/Degradation Specification: presence of N-nitroso Prazosin imp…

Sucralfate Tablets recalled over manufacturing violations

October 9, 2025 · Drug & medication recalls Moderate risk CGMP Deviations: The recalling firm filed for Chapter 11 on September 30, 2024.…

Amerisource Health Services LLC recalls chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, packaged as a) 50 (5x10) blisterpacks, NDC: 60687-430-65; (Individual…

August 27, 2025 · Drug & medication recalls Moderate risk Presence of a foreign substance.A specific lot of auxiliary polyester coil, use…

Amerisource Health Services LLC recalls chlorproMAZINE Hydrochloride Tablets, USP, 100 mg, 100 (10x10) blisterpack per carton, Rx Only, Distributed by: America…

August 27, 2025 · Drug & medication recalls Moderate risk Presence of a foreign substance.A specific lot of auxiliary polyester coil, use…

Amerisource Health Services LLC recalls chlorproMAZINE Hydrochloride Tablets, USP, 50 mg, 100 (10x10) blisterpacks, Rx Only, Distributed by: American Health Pa…

August 27, 2025 · Drug & medication recalls Moderate risk Presence of a foreign substance.A specific lot of auxiliary polyester coil, use…

Amerisource Health Services LLC recalls chlorproMAZINE Hydrochloride Tablets, USP, 200 mg, 100 (10x10) blisterpack per carton, Rx Only, Distributed by: America…

August 27, 2025 · Drug & medication recalls Moderate risk Presence of a foreign substance.A specific lot of auxiliary polyester coil, use…

Sucralfate Tablets recalled over manufacturing violations

July 29, 2025 · Drug & medication recalls Moderate risk CGMP Deviations: The recalling firm filed for Chapter 11 in September 2024. As…

Indomethacin Extended-Release Capsules recalled over manufacturing violations

May 15, 2025 · Drug & medication recalls Moderate risk cGMP deviations

Haloperidol Decanoate Injection recalled over sterility concerns

April 2, 2025 · Drug & medication recalls Moderate risk Lack of assurance of sterility. Bacterial contamination detected in some media…

Haloperidol Decanoate Injection recalled over sterility concerns

April 2, 2025 · Drug & medication recalls Moderate risk Lack of assurance of sterility. Bacterial contamination detected in some media…

Haloperidol Decanoate Injection recalled over sterility concerns

April 2, 2025 · Drug & medication recalls Moderate risk Lack of assurance of sterility. Bacterial contamination detected in some media…

Voriconazole Tablets recalled over manufacturing violations

March 24, 2025 · Drug & medication recalls Moderate risk cGMP Deviations: Received notification from their supplier requesting they perf…

Duloxetine Delayed-Release Capsules recalled over manufacturing violations

December 6, 2024 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommende…

Duloxetine Delayed-Release Capsules USP recalled over manufacturing violations

December 6, 2024 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommende…

Duloxetine Delayed-Release Capsules USP recalled over manufacturing violations

December 6, 2024 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommende…

Duloxetine Delayed-Release Capsules recalled over manufacturing violations

December 6, 2024 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommende…

Duloxetine Delayed-Release Capsules recalled over manufacturing violations

November 14, 2024 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommende…

Duloxetine Delayed-Release Capsules recalled over manufacturing violations

November 14, 2024 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommende…

Duloxetine Delayed-Release Capsules recalled over manufacturing violations

November 14, 2024 · Drug & medication recalls Moderate risk CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommende…